Cargando…

Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas

BACKGROUND: Prognosis of children with primary disseminated or metastatic relapsed sarcomas remains dismal despite intensification of conventional therapies including high-dose chemotherapy. Since haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is effective in the treatment of he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eichholz, Thomas, Döring, Michaela, Giardino, Stefano, Gruhn, Bernd, Seitz, Christian, Flaadt, Tim, Schwinger, Wolfgang, Ebinger, Martin, Holzer, Ursula, Mezger, Markus, Teltschik, Heiko-Manuel, Sparber-Sauer, Monika, Koscielniak, Ewa, Abele, Michael, Handgretinger, Rupert, Lang, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990259/ https://www.ncbi.nlm.nih.gov/pubmed/36895486 http://dx.doi.org/10.3389/fonc.2023.1064190

Ejemplares similares

Treatment of graft failure with TNI‐based reconditioning and haploidentical stem cells in paediatric patients
por: Teltschik, Heiko‐Manuel, et al.
Publicado: (2016)

Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial
por: Flaadt, Tim, et al.
Publicado: (2023)

Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment
por: Seitz, Christian Martin, et al.
Publicado: (2021)

Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation
por: Wegener, D., et al.
Publicado: (2021)

Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
por: Döring, Michaela, et al.
Publicado: (2012)

Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol
por: Koscielniak, Ewa, et al.
Publicado: (2022)

Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse
por: Flaadt, Tim, et al.
Publicado: (2023)

Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
por: Cabanillas Stanchi, Karin Melanie, et al.
Publicado: (2020)

Removal of CD276(+) cells from haploidentical memory T-cell grafts significantly lowers the risk of GVHD
por: Hashimoto, Hisayoshi, et al.
Publicado: (2021)

Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia – role of blinatumomab
por: Queudeville, Manon, et al.
Publicado: (2017)

Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation
por: Döring, Michaela, et al.
Publicado: (2015)

Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies
por: Cabanillas Stanchi, Karin Melanie, et al.
Publicado: (2019)

NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation
por: Merli, Pietro, et al.
Publicado: (2022)

Safety and Tolerance of Donor-Derived Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation: The MYSTEP1 Study
por: Hartleif, Steffen, et al.
Publicado: (2017)

Treatment and outcome of the patients with rhabdomyosarcoma of the biliary tree: Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS)
por: Urla, Cristian, et al.
Publicado: (2019)

Antiemetic Prophylaxis with Fosaprepitant and 5-HT(3)-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
por: Cabanillas Stanchi, Karin Melanie, et al.
Publicado: (2020)

Inadvertent intravenous administration of maternal breast milk in a six-week-old infant: a case report and review of the literature
por: Döring, Michaela, et al.
Publicado: (2014)

NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML
por: Schlegel, Patrick, et al.
Publicado: (2015)

Diagnostic value of whole-body MRI in Opsoclonus-myoclonus syndrome: a clinical case series (3 case reports)
por: Storz, Corinna, et al.
Publicado: (2019)

Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies
por: Antony, Justin S., et al.
Publicado: (2015)

Recurrent SARS-CoV-2 Infection and Impaired Immunologic Response in a Pediatric Oncologic Patient While Treated With Radiochemotherapy
por: Eichholz, Thomas, et al.
Publicado: (2022)

CRISPR medicine for blood disorders: Progress and challenges in delivery
por: Mohammadian Gol, Tahereh, et al.
Publicado: (2023)

Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis
por: Döring, Michaela, et al.
Publicado: (2012)

T-cell responses against CD19(+) pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts
por: Feucht, Judith, et al.
Publicado: (2016)

Fulminant Rhizomucor pusillus mucormycosis during anti-leukemic treatment with blinatumomab in a child: A case report and review of the literature
por: Schober, Sarah, et al.
Publicado: (2020)

In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment
por: Grote, Stefan, et al.
Publicado: (2021)

Characterisation of the Cell Line HC-AFW1 Derived from a Pediatric Hepatocellular Carcinoma
por: Armeanu-Ebinger, Sorin, et al.
Publicado: (2012)

Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies
por: Gao, Xiao-Ning, et al.
Publicado: (2018)

Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia
por: Döring, M., et al.
Publicado: (2015)

Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients
por: Schroeder, Christopher, et al.
Publicado: (2023)

Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation
por: Schneider, Veronika, et al.
Publicado: (2023)

Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity
por: Johann, Pascal-David, et al.
Publicado: (2010)

Editorial to: Advance in the Treatment of Pediatric Leukemia
por: Handgretinger, Rupert
Publicado: (2022)

Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials
por: Tramsen, Lars, et al.
Publicado: (2023)

Advances in haploidentical stem cell transplantation
por: Bayraktar, Ulas Darda, et al.
Publicado: (2011)

Overview of the progress on haploidentical hematopoietic transplantation
por: Farhadfar, Nosha, et al.
Publicado: (2016)

The Evolution of T Cell Depleted Haploidentical Transplantation
por: Aversa, Franco, et al.
Publicado: (2019)

Review of Haploidentical Hematopoietic Cell Transplantation
por: Khan, Mehreen A., et al.
Publicado: (2018)

Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL
por: Ureña-Bailén, Guillermo, et al.
Publicado: (2022)

Th1 cytokines in pediatric acute lymphoblastic leukemia
por: Schober, Sarah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_un0rlith4gvcedp7nk2c7klmqn